Abiomed Inc (ABMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
03-2022 | 03-2021 | 03-2020 | 03-2019 | 03-2018 | |
Assets | |||||
Current Assets | |||||
Cash & Cash Equivalents | 132,818 | 232,710 | 192,341 | 121,021 | 42,975 |
Marketable Securities | 625,789 | 350,985 | 250,775 | 370,677 | 319,274 |
Receivables | 90,608 | 97,179 | 84,650 | 90,809 | 70,010 |
Inventories | 93,981 | 81,059 | 90,088 | 80,942 | 50,204 |
TOTAL | $976,473 | $787,965 | $635,863 | $677,197 | $494,271 |
Non-Current Assets | |||||
PPE Net | 202,490 | 197,129 | 164,931 | 145,005 | 117,167 |
Investments And Advances | 220,089 | 264,085 | 207,795 | 21,718 | 37,502 |
Intangibles | 116,304 | 120,718 | 46,882 | 32,601 | 35,808 |
Other Non-Current Assets | 158,037 | 124,462 | 160,991 | 177,825 | 101,627 |
TOTAL | $696,920 | $706,394 | $580,599 | $377,149 | $292,104 |
Total Assets | $1,673,393 | $1,494,359 | $1,216,462 | $1,054,346 | $786,375 |
Liabilities | |||||
Current Liabilities | |||||
Accounts payable and accrued liabilities | 35,346 | 34,842 | 32,774 | 32,185 | 23,565 |
Accrued Expenses | 72,629 | 66,046 | 75,107 | 57,420 | 46,147 |
Other current liabilities | 4,120 | 3,759 | 4,857 | N/A | N/A |
TOTAL | $138,457 | $128,969 | $131,885 | $105,998 | $84,682 |
Non-Current Liabilities | |||||
Deferred Revenues | 26,362 | 24,322 | 19,147 | 16,393 | 14,970 |
Other Non-Current Liabilities | 30,829 | 34,868 | 18,305 | 10,636 | 11,266 |
TOTAL | $31,610 | $35,715 | $19,111 | $11,458 | $12,169 |
Total Liabilities | $170,067 | $164,684 | $150,996 | $117,456 | $96,851 |
Shareholders' Equity | |||||
Shares Outstanding, K | 45,564 | 45,296 | 44,957 | 45,125 | 44,478 |
Common Shares | 455 | 453 | 451 | 451 | 444 |
Retained earnings | 964,512 | 828,007 | 602,482 | 399,473 | 140,457 |
Other shareholders' equity | -26,715 | -11,475 | -11,600 | -14,541 | -4,282 |
TOTAL | $1,503,326 | $1,329,675 | $1,065,466 | $936,890 | $689,524 |
Total Liabilities And Equity | $1,673,393 | $1,494,359 | $1,216,462 | $1,054,346 | $786,375 |